Xiaolu WANG, Yong ZHAO, Xinhe ZUO, et al. Research progress on effect of oxidative stress in thyroid cancer and intervention of Chinese medicine monomer in vitro. [J]. Shanghai Journal of Traditional Chinese Medicine 55(10):79-83(2021)
DOI:
Xiaolu WANG, Yong ZHAO, Xinhe ZUO, et al. Research progress on effect of oxidative stress in thyroid cancer and intervention of Chinese medicine monomer in vitro. [J]. Shanghai Journal of Traditional Chinese Medicine 55(10):79-83(2021) DOI: 10.16305/j.1007-1334.2021.2101089.
Research progress on effect of oxidative stress in thyroid cancer and intervention of Chinese medicine monomer in vitro
The research progress on the effect of oxidative stress in thyroid cancer and intervention of Chinese medicine monomer in vitro were reviewed. Oxidative stress affected the process of thyroid cancer in a paradoxical way, it not only participated in the formation and development of tumors, but also led to the death of cancer cells; the accumulation of reactive oxygen species was involved in the occurrence and progression of thyroid cancer, which could also lead to the migration and invasion of cancer cells. There were some Chinese medicine monomers such as parthenolide, icariin, triptolide, crocin, artesunate, curcumin, salvianolic acid B, puerarin and shikonin could cause the accumulation of oxidative substances in thyroid cancer cells in vitro, reduce the production of antioxidant enzymes, thereby inducing the apoptosis of thyroid cancer cells, etc., so as to exert its therapeutic effect.
关键词
氧化应激甲状腺癌细胞凋亡中药单体综述
Keywords
oxidative stressthyroid cancercell apoptosisChinese medicine monomerreview
TALIB W H, AL-ATABY I A, MAHMOD A I, et al. The impact of herbal infusion consumption on oxidative stress and cancer: the good, the bad, the misunderstood[J]. Molecules, 2020, 25(18): 4207.
AHMADI A, SHADBOORESTAN A. Oxidative stress and cancer: the role of hesperidin, a citrus natural bioflavonoid, as a cancer chemoprotective agent[J]. Nutr Cancer, 2016, 68(1): 29-39.
CAMMAROTA F, FISCARDI F, ESPOSITO T, et al. Clinical relevance of thyroid cell models in redox research[J]. Cancer Cell Int, 2015, 15(1): 1-14.
BRAUN J, HÜTTELMAIER S. Pathogenic mechanisms of deregulated microRNA expression in thyroid carcinomas of follicular origin[J]. Thyroid Res, 2011, 4(1): 1-11.
KARBOWNIK-LEWIŃSKA M, KOKOSZKO-BILSKA A.Oxidative damage to macromolecules in the thyroid-experimental evidence[J]. Thyroid Res, 2012, 5(1): 1-6.
KROHN K, MAIER J, PASCHKE R. Mechanisms of disease: hydrogen peroxide, DNA damage and mutagenesis in the development of thyroid tumors[J]. Nat Clin Pract Endocrinol Metab, 2007, 3(10): 713-720.
TABUR S, AKSOY Ș N, KORKMAZ H, et al. Investigation of the role of 8-OHdG and oxidative stress in papillary thyroid carcinoma[J]. Tumor Biol, 2015, 36(4): 2667-2674.
ECE H, MEHMET E, CIGIR B A, et al. Serum 8-OHdG and HIF-1α levels: do they affect the development of malignancy in patients with hypoactive thyroid nodules?[J]. Contemp Oncol (Pozn), 2013, 17(1): 51-57.
DONMEZ-ALTUNTAS H, BAYRAM F, BITGEN N, et al. Increased chromosomal and oxidative DNA damage in patients with multinodular goiter and their association with cancer[J/OL]. Int J Endocrinol, 2017[2021-01-03]. https://pubmed.ncbi.nlm.nih.gov/28373882/https://pubmed.ncbi.nlm.nih.gov/28373882/.
DERWAHL M, NICULA D. Estrogen and its role in thyroid cancer[J]. Endocr Relat Cancer, 2014, 21(5): 273-283.
FAN D, LIU S Y W, VAN HASSELT C A, et al. Estrogen receptor α induces prosurvival autophagy in papillary thyroid cancer via stimulating reactive oxygen species and extracellular signal regulated kinases[J]. J Clin Endocrinol Metab, 2015, 100(4): 561-571.
SOSA V, MOLINÉ T, SOMOZA R, et al. Oxidative stress and cancer: an overview[J]. Ageing Res Rev, 2013, 12(1): 376-390.
LIAO C W, ZHENG C, WANG L. Down-regulation of FOXR2 inhibits hypoxia‐driven ROS‐induced migration and invasion of thyroid cancer cells via regulation of the hedgehog pathway[J]. Clin Exp Pharmacol Physiol, 2020, 47(6): 1076-1082.
JOHN D H, ALBENA T D K, KENNETH D T. Oxidative stress in cancer[J]. Cancer Cell, 2020, 38(2): 167-197.
ROVCANIN B R, GOPCEVIC K R, KEKIC D L, et al. Papillary thyroid carcinoma: A malignant tumor with increased antioxidant defense capacity[J]. Tohoku J Exp Med, 2016, 240(2): 101-111.
UNLUHIZARCI K, KIRIS A, KOSE K, et al. Thyroid hormone withdrawal further exacerbates oxidative stress in patients with thyroid carcinoma[J]. Exp Clin Endocrinol Diabetes, 2016, 124(4): 225-229.
STANLEY J A, NEELAMOHAN R, SUTHAGAR E, et al. Lipid peroxidation and antioxidants status in human malignant and non-maligant thyroid tumours[J]. Hum Exp Toxicol, 2016, 35(6): 585-597.
RECZEK C R, BIRSOY K, KONG H, et al. A CRISPR screen identifies a pathway required for paraquat-induced cell death[J]. Nat Chem Biol, 2017, 13(12): 1274-1279.
HU K H, LI W X, SUN M Y, et al. Cadmium induced apoptosis in MG63 cells by increasing ROS, activation of p38 MAPK and inhibition of ERK 1/2 pathways[J]. Cell Physiol Biochem, 2015, 36(2): 642-654.
REDZA-DUTORDOIR M, AVERILL-BATES D A. Activation of apoptosis signalling pathways by reactive oxygen species[J]. Biochim Biophys Acta, 2016, 1863(12): 2977-2992.
BAGHERI-YARMAND R, SINHA K M, LI L, et al. Combinations of tyrosine kinase inhibitor and ERAD inhibitor promote oxidative stress-induced apoptosis through ATF4 and KLF9 in medullary thyroid cancer[J]. Mol Cancer Res, 2019, 17(3): 751-760.
ZHANG Y, ZHU M, KRISHNA MOHAN S, et al. Crocin treatment promotes the oxidative stress and apoptosis in human thyroid cancer cells FTC‐133 through the inhibition of STAT/JAK signaling pathway[J]. J Biochem Mol Toxicol, 2020, 35(1): e22608.
SULLIVAN L B, CHANDEL N S. Mitochondrial reactive oxygen species and cancer[J]. Cancer Metab, 2014, 2(1): 1-12.
YUAN L, WANG Z, ZHANG D, et al. Metabonomic study of the intervention effects of Parthenolide on anti-thyroid cancer activity[J/OL]. J Chromatogr B Analyt Technol Biomed Life Sci, 2020 [2021-01-03]. https://pubmed.ncbi.nlm.nih.gov/32506011/https://pubmed.ncbi.nlm.nih.gov/32506011/.
MA L, FEI H. Antimalarial drug artesunate is effective against chemoresistant anaplastic thyroid carcinoma via targeting mitochondrial metabolism[J]. J Bioenerg Biomembr, 2020, 52(2): 1-8.
ZHENG X, JIA B, TIAN X T, et al. Correlation of reactive oxygen species levels with resveratrol sensitivities of anaplastic thyroid cancer cells[J]. Oxid Med Cell Longev, 2018, 20(8): 1-12
郑旭. 白藜芦醇对甲状腺癌防治作用的实验研究[D]. 大连:大连医科大学,2018.
宋菲. 姜黄素对甲状腺癌细胞影响的实验研究[D]. 无锡:江南大学,2012.
TAN C, ZHANG L, CHENG X, et al. Curcumin inhibits hypoxia-induced migration in K1 papillary thyroid cancer cells[J]. Exp Biol Med, 2015, 240(7): 925-935.